A detailed history of Marshall Wace, LLP transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 16,216 shares of TKNO stock, worth $139,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,216
Holding current value
$139,457
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $5.17 $19,459 - $83,836
16,216 New
16,216 $78,000

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $241M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.